<

 
Data updated 2025-06-27 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date18214711.6 (espacenet)  (Federated)  (European Patent Register), 20141113
Patent/reg. no. and dateDK/EP 3492593, 20210818
Publication date20190605
Priority no. and dateUS 201361903823 P, 20131113, US 201462042075 P, 20140826
EP pub. no. and date EP 3492593 20190605
Effective date
Applicant/ownerChildren's Medical Center Corporation, 55 Shattuck Street
Boston, MA 02115, US,
Sangamo Therapeutics, Inc., 7000 Marina Blvd
Brisbane, CA 94005, US
Applicant ref. no.1605801
InventorORKIN, Stuart H., c/o Children's Medical Center Corporation
55 Shattuck Street
Boston, MA Massachusetts 02115, US,
REIK, Andreas, c/o Sangamo Therapeutics, Inc.
7000 Marina Blvd
Brisbane
CA 94005, US,
URNOV, Fyodor, c/o Sangamo Therapeutics, Inc.
7000 Marina Blvd
Brisbane
CA 94005, US
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB, GB
Opponent
IPC ClassA61K 35/12 (2015.01) , A61K 35/28 (2015.01) , A61K 38/46 (2006.01) , A61P 7/00 (2006.01) , C07K 14/47 (2006.01) , C12N 15/09 (2006.01) , C12N 15/113 (2010.01) , C12N 9/22 (2006.01) 
TitleNUKLEASEMEDIERET REGULERING AF GENEKSPRESSION
Int. application no.
Int. publication no.
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact